CD79A and malaria: For malaria, an intranasal vaccine could theoretically intercept sporozoites that lodge in the lung microvasculature (Figure 3), whereas an oral vaccine might stimulate gut-associated lymphoid tissue, seeding IgA-producing B cells throughout mucosal and systemic sites (Macpherson et al., 2008).